In this study, we present the results from two groups of patients with increased PSA plasma levels undergoing 68Ga-PSMA-11 PET/CT (n = 25) or 18FEC PET/CT (n = 40) and imaging guided biopsy to detect significant cancer of the prostate. This evidence concerns the gene FOLH1 and prostate carcinoma.